Drug Prices | Arnold Ventures

Prescription drugs

Prescription Drug Importation Fuels More Questions than Answers

'Evergreening' Stunts Competition, Costs Consumers and Taxpayers

President Trump’s 'Most Favored Nation' Executive Order Won’t Lower Drug Prices Immediately

Analysis: U.S. Pays Substantially More than Australia for the Same Prescription Drugs

Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices

In Pandemic, Pharma Attempts an Image Reset — But Americans Still Want Pricing Reform

Pills at a pharmacy

'Canary in a Coal Mine': Expensive Brand-Name Drugs Thrive in Medicare Part D Despite Generic Competition, Driving Up Costs

'Buy American' Rule Aimed at Lessening Dependence on Foreign Drug Manufacturing Could Lead to Higher Prices Explainer

Seema Verma

A Letter to CMS on the Proposed Medicaid Rule

Executive Orders Unlikely to Lower Drug Prices

To Lower Drug Costs, Tap Pharmacists for Help

Gilead Sets Two Separate Prices for its COVID-19 Drug in the United States, Charging More to Treat Most Americans

A Reflection on the Biosimilar Pathway As it Turns 10 Years Old

Study: Blocking Generic Drugs is a Costly and Common Pharma Tactic

COVID-19 Reveals Fissures in the Nation’s Prescription Drug Supply Chain

Why Nonprofit Pharma, a Promising Fix for Drug Prices, Faces an Uphill Battle

Community Supervision

Four Key Moments from Trump's State of the Union Address

Video: An 'Erosion' of Protection: The State of Health Care in America

As Democrats Debate in Des Moines, Health Care Reform Tops Iowans' Wish Lists

A Small Win on Drug Pricing Was Added to the U.S. Budget, but Does it Go Far Enough?

Laboratories of Democracy: States Ring in New Year with Ambitious New Health Laws

A Landmark Drug Pricing Bill Just Cleared the House. Now What?

With New Chief in the Wings, Here’s How the FDA Could Wield Influence to Lower Drug Prices

‘The Time to Act Is Now’ on Drug Pricing

More stories from:

Criminal Justice